Trials / Conditions / Vaccines, Pneumococcal

Vaccines, Pneumococcal

13 registered clinical trials studyying Vaccines, Pneumococcal.

Status	Trial	Sponsor	Phase
Completed	Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US NCT01086397	Pfizer	—
Completed	Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico NCT00708682	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants NCT00474539	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants NCT00444457	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants NCT00366548	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. NCT00368966	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants NCT00366678	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. NCT00366340	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants NCT00384059	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants NCT00366899	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine NCT00373958	Pfizer	Phase 3
Completed	Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa NCT00294294	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4
Completed	Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children NCT00580684	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4